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Pulmonary 
Infection Caused 
by Mycobacterium 
conceptionense
To the Editor: Mycobacterium 
conceptionense was fi rst identifi ed 
in 2006 from a patient with 
posttraumatic osteitis (1). Since then, 
3 more isolates have been recovered 
from a subcutaneous abscess (2), a 
wound after breast surgery (3), and an 
abscess after a fat injection (4). During 
November 2009 through April 2010, 
M. conceptionense was isolated from 
sputum from 4 patients in 2 tertiary 
hospitals in South Korea.
Patient 1, a 69-year-old woman, 
was admitted to Seoul National 
University Bundang Hospital in 2005 
with fever and pleuritic chest pain. She 
had a long history of recurrent fever 
and cough. Computed tomography 
(CT) showed multifocal nodular lung 
lesions with lymphadenopathy. After 
7 days of treatment with cefuroxime 
and azithromycin, the patient’s fever 
subsided and radiographic lesions 
disappeared. She was discharged 
with negative culture results. After 
discharge, she had recurrent episodes 
of fever, and CT showed waxing 
and waning pulmonary lesions. 
Nontuberculous mycobacteria (NTM) 
species were isolated from some 
sputum cultures: M. smegmatis in 
2006; M. avium in 2007; and M. 
intracellulare in 2008 and 2009. 
In February and April 2010, her 
respiratory symptoms and chest 
CT fi ndings indicated more severe 
disease, and M. conceptionense grew 
in sputum cultures. After treatment 
with clarithromycin, rifampin, and 
ethambutol for 2 months, the patient’s 
symptoms improved and sputum 
culture results were negative.
Patient 2, a 70-year-old man with 
Parkinson disease, was referred to 
Seoul National University Bundang 
Hospital in November 2009 for a small 
nodular lung lesion detected by CT 
during a medical checkup. He exhibited 
no pulmonary symptoms. Routine 
laboratory test results were within 
normal limits. M. conceptionense was 
isolated from sputum. Clarithromycin 
was prescribed for 10 days, and the 
patient remains asymptomatic.
Patient 3, a 70-year-old man 
with tongue cancer, was admitted to 
Seoul National University Hospital 
in March 2010 with exacerbated 
dyspnea. In November 2009, CT had 
indicated new nodular lung lesions 
and chemotherapy had been started. 
Chest CT in 2010 showed increased 
size and extent of nodular infi ltration, 
which suggested pulmonary infection 
rather than cancer metastasis. From 
2 sputum samples, 2 isolates of M. 
conceptionense were identifi ed. In 
addition, Streptococcus pneumoniae 
grew in blood and sputum cultures. 
Despite treatment with broad-
spectrum antimicrobial drugs, the 
patient died of respiratory failure.
Patient 4, a 53-year-old man, 
sought care at Seoul National 
University Hospital in 2008 for chest 
discomfort. Other than having diabetes 
mellitus, he had been healthy. Chest 
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CT showed multiple lung nodules. 
Sputum culture grew M. tuberculosis. 
The patient received isoniazid, 
rifampin, ethambutol, and levofl oxacin 
for 6 months, during which time 
sputum cultures were negative. In 
April 2010, follow-up sputum culture 
grew M. conceptionense. The patient 
was asymptomatic and followed up 
without treatment.
Cultures for each patient were 
conducted at the respective hospitals, 
where sputum specimens were 
placed on solid media (Ogawa; 
Shinyang, Seoul, South Korea) and 
in liquid media (MGIT 960; Becton 
Dickinson, Sparks, MD, USA) after 
decontamination with NaOH. For all 6 
specimens, acid-fast bacilli grew 4–7 
days after incubation in liquid media.
Molecular identifi cation was con-
ducted at Seoul National University 
Bundang Hospital, where PCR re-
striction fragment length poly-
morphism and multiplex real-time 
PCR and melting curve analyses 
were performed as described (5,6). 
Each method produced identical 
results for all but did not support 
specifi c identifi cation. PCR restriction 
fragment length polymorphism 
profi les and melting peaks for the 
isolates from patients 1–4 were 
similar to those of M. septicum and M. 
fortuitum. Sequence analyses of the 
652-bp fragment of tuf and the 527-
bp and 1,571-bp fragments of 16S 
rDNA genes were performed (7,8). 
The tuf sequences of isolates from 
patients 1, 3, and 4 showed 100% 
identity with the M. conceptionense 
type strain, 98.2% homology (11-bp 
difference) with M. porcinum, and 
98.1% homology with M. fortuitum. 
The tuf sequence of the isolate from 
patient 2 differed by 2 bp from the 
others. The 16S rDNA sequence of 
the isolate from patient 1 showed 
100% homology with sequences of M. 
conceptionense and M. senegalense 
and 99.9% (2-bp difference) 
homology with M. farcinogenes. 
Broth microdilution susceptibility 
tests for isolates from patients 1, 2, and 
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Table. Summary of cases of Mycobacterium conceptionense infection* 
Patient
no.
Age, y/ 
sex 
Underlying 
illness Clinical presentation
M. conceptionense
source
Sequencing
results† Treatment Outcome Ref 
1 69/F Chronic lung 
disease
Chronic cough and 
recurrent fever; 
multifocal lung lesion 
and
lymphadenopathy 
seen on chest CT 
image
Sputum (2u) tuf, 16S rDNA 
(1,441 and 
458 bp; 100% 
match)
CLA, RIF, 
EMB
Improved after 
2 mo treatment 
This 
article
2 70/M Parkinson 
disease
Asymptomatic; small 
nodule seen on 
chest CT image 
Sputum (1u) tuf CLA Asymptomatic This 
article
3 70/M Tongue 
cancer
Respiratory failure, 
Streptococcus
pneumoniae
septicemia; lung 
lesion on chest CT 
image
Sputum (2u) tuf, 16S rDNA 
(400 and 460 
bp; 100% 
match)
CLA, LVX, 
IPM, AMK, 
VAN
Died This 
article
4 53/M Lung 
tuberculosis
Asymptomatic after 
completion of 
antituberculosis
treatment  
Sputum (1u) tuf, 16S rDNA 
(459 bp; 100% 
match)
Observation Asymptomatic This 
article
5‡ 31/F Posttraumatic 
osteitis 
Wound liquid outflow 
3 mo after treatment 
for open fracture 
Wound liquid, bone 
tissue biopsy, 
excised skin tissue 
16S rDNA, 
soda, hsp65,
recA, rpoB
AMC Not reported (1)
6‡ 43/F Subcutaneous 
abscess
without trauma 
Painful swelling and 
erythematous ankle; 
abscess detected by 
MRI
Abscess aspirate 16S rDNA 
(1,464 bp) 
COT, CLA, 
DOX, LIN 
Improved after 
5 mo treatment 
(2)
7‡ 58/F Breast implant 
infection
Fever and wound 
discharge
Wound discharge, 
surgical drainage 
rpoB CIP, AZY, 
DOX 
Unremarkable 
results at 2-mo 
follow-up after 
18 mo 
treatment 
(3)
8 50/F Face surgery 
with fat 
grafting 
Erythematous 
nodules and purulent 
discharge
Wound discharge 16S rDNA, 
rpoB 
AMK, LVX, 
CFX, CLA, 
SXT
Recovered after 
1 mo treatment 
(4)
*Ref, reference; CT, computed tomography; CLA, clarithromycin; RIF, rifampin; EMB, ethambutol; LVX, levofloxacin; IPM, imipenem; AMK, amikacin; 
VAN, vancomycin; AMC, amoxicillin/clavulanic acid; MRI, magnetic resonance imaging COT, cotrimoxazole; DOX, doxycycline; LIN, linezolid; CIP, 
ciprofloxacin; AZY, azithromycin; CFX, cefoxitin; SXT, sulfamethoxazole/trimethoprim. 
†Sequences of the isolates were compared with the tuf gene and 16S rDNA gene sequence of the type strain CIP 108544T (GenBank accession nos. 
EU191943.1 and AY859684.1, respectively). 
‡Data modified from Thibeaut et al. (3).
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4 showed susceptibility to amikacin, 
ciprofl oxacin, clarithromycin, and 
doxycycline but resistance to cefoxitin, 
sulfamethoxazole, rifampin (MIC >16 
μg/mL) and intermediate-resistance to 
imipenem (MIC 8–16 μg/mL).
According to the American 
Thoracic Society diagnostic criteria 
for NTM lung disease (9), patient 1 
fulfi lled all criteria and patient 3 ful-
fi lled the radiographic and micro-
biological criteria. These fi ndings 
suggest that M. conceptionense 
can cause lung disease. For the 
other patients, colonization with M. 
conceptionense is a more plausible 
explanation (Table).
These 4 recent cases of M. 
conceptionense infection are in 
accordance with the increasing 
prevalence of NTM (10). Increasing 
prevalence might be the result 
of technical advances in NTM 
identifi cation, including use of liquid 
media and sequencing, or the result 
of a local outbreak or contamination 
event. We consider contamination 
to be an unlikely cause because 
specimens were completely separated 
from each other during collection and 
testing. Isolates from different patients 
yielded distinct randomly amplifi ed 
polymorphic DNA patterns. In 
conclusion, M. conceptionense is not a 
rare NTM species in South Korea and 
can cause pulmonary disease.
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Mycobacterium 
riyadhense 
Pulmonary 
Infection, 
France and Bahrain
To the Editor: Mycobacterium 
riyadhense is a newly described 
mycobacterial species that is 
potentially pathogenic for humans. 
Extrapulmonary infection with this 
nontuberculous mycobacterium 
(NTM) has been reported (1).We 
report 2 cases of pulmonary infection 
with this NTM.
The fi rst case of infection was in a 
39-year-old woman who was admitted 
to Toulon Military Hospital, Toulon, 
France, in December 2005 with 
suspected pulmonary tuberculosis. For 
1 month, the patient had a persistent 
cough, fever, asthenia, and weight 
loss. Findings on chest radiographs 
were suggestive of tuberculosis, with 
cavitation in the right upper lobe, and 
the tuberculin skin test reaction was 
positive. Sputum specimens collected 
on 3 consecutive days were negative 
for acid-fast bacilli (AFB), but broth 
cultures (BacT/ALERT 3D system; 
bioMérieux, Marcy l’Etoile, France) 
yielded mycobacterial growth.
We used 4 multiplex line-probe 
assays to identify the mycobacteria: 
GenoType MTBC (Hain Lifescience, 
Nehren, Germany) identifi ed the 
organisms as members of the M. 
tuberculosis complex (MTBC; with a 
nonspecifi c reaction, banding pattern 
1, 2, 3); GenoType Mycobacterium 
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